The cytokine network of acute HIV infection: a promising target for vaccines and therapy to reduce viral set-point?
about
Clinical development of candidate HIV vaccines: different problems for different vaccinesBlocking TLR7- and TLR9-mediated IFN-α production by plasmacytoid dendritic cells does not diminish immune activation in early SIV infectionEffect of mild-to-moderate smoking on viral load, cytokines, oxidative stress, and cytochrome P450 enzymes in HIV-infected individualsImmunopathogenesis of simian immunodeficiency virus infection in nonhuman primatesAcute plasma biomarkers of T cell activation set-point levels and of disease progression in HIV-1 infection.Induction of SerpinB2 and Th1/Th2 modulation by SerpinB2 during lentiviral infections in vivoPrior virus exposure alters the long-term landscape of viral replication during feline lentiviral infection.Multiplexed Component Analysis to Identify Genes Contributing to the Immune Response during Acute SIV Infection.Fast disease progression in simian HIV-infected female macaque is accompanied by a robust local inflammatory innate immune and microbial responseAssociation of Cytokines With Exosomes in the Plasma of HIV-1-Seropositive IndividualsPQBP1 Is a Proximal Sensor of the cGAS-Dependent Innate Response to HIV-1.The Cross-Sectional Association of Energy Intake and Dietary Energy Density with Body Composition of Children in Southwest ChinaReconciling Longitudinal Naive T-Cell and TREC Dynamics during HIV-1 InfectionRapid and Slow Progressors Show Increased IL-6 and IL-10 Levels in the Pre-AIDS Stage of HIV Infection.Impairment of T cell development and acute inflammatory response in HIV-1 Tat transgenic miceEarly Gag immunodominance of the HIV-specific T-cell response during acute/early infection is associated with higher CD8+ T-cell antiviral activity and correlates with preservation of the CD4+ T-cell compartment.Toll-like receptor 7 inhibits early acute retroviral infection through rapid lymphocyte responsesThe role of cytokines in the establishment, persistence and eradication of the HIV reservoirDynamics of cytokine/chemokine responses in intestinal CD4+ and CD8+ T Cells during Acute Simian Immunodeficiency Virus InfectionCharacterization of Simian Immunodeficiency Virus Variants Anatomically Compartmentalized in Plasma and Milk in Chronically Infected African Green MonkeysMagnitude and Quality of Cytokine and Chemokine Storm during Acute Infection Distinguish Nonprogressive and Progressive Simian Immunodeficiency Virus Infections of Nonhuman PrimatesThe Significance of Interferon-γ in HIV-1 Pathogenesis, Therapy, and Prophylaxis.IFN-ε protects primary macrophages against HIV infectionPlasma Cytokine Levels in Chronic Asymptomatic HIV-1 Subtype C Infection as an Indicator of Disease Progression in Botswana: A Retrospective Case Control Study.Dynamics of innate immunity are key to chronic immune activation in AIDS.Biosensor technology: recent advances in threat agent detection and medicine.On-chip immune cell activation and subsequent time-resolved magnetic bead-based cytokine detection.Transcriptional Regulation of CXCL5 in HIV-1-Infected Macrophages and Its Functional Consequences on CNS Pathology.IP-10 Levels as an Accurate Screening Tool to Detect Acute HIV Infection in Resource-Limited Settings.Early initiation of antiretroviral treatment postSIV infection does not resolve lymphoid tissue activation.Cytokine cascade and networks among MSM HIV seroconverters: implications for early immunotherapy.Effect of Probiotic Supplement on Cytokine Levels in HIV-Infected Individuals: A Preliminary Study.HIV-1 Tat protein induces PD-L1 (B7-H1) expression on dendritic cells through tumor necrosis factor alpha- and toll-like receptor 4-mediated mechanisms.Defective iron homeostasis in human immunodeficiency virus type-1 latency.Comparative Analysis of Tat-Dependent and Tat-Deficient Natural Lentiviruses.Cytokine biosensors: the future of infectious disease diagnosis?Chemokines and Chemokine Receptors: Accomplices for Human Immunodeficiency Virus Infection and Latency.Dynamics of CD4 and CD8 T-Cell Subsets and Inflammatory Biomarkers during Early and Chronic HIV Infection in Mozambican Adults.Biomarkers of Progression after HIV Acute/Early Infection: Nothing Compares to CD4⁺ T-cell Count?Optimizing HIV-1-specific CD8+ T-cell induction by recombinant BCG in prime-boost regimens with heterologous viral vectors
P2860
Q27005008-784B1D02-E568-470F-A7F3-F27F651DB6FAQ27334176-9B3F6878-183E-4194-B92C-B74E22CD52CCQ28260551-80D5A710-CCAA-42F7-9625-944BE3218C67Q33355730-597BCEB4-6005-4FA3-86F6-FCA1667E4E85Q34441167-0B28EA84-3614-41EF-BBAE-2B7DF56FC8FBQ34608495-678E7863-5769-43F8-BABF-C3D0D76F2AD8Q35491719-AEAE2FA0-42A7-4C17-BEE0-4D9FD03263F9Q35634100-48408423-1C20-4072-B937-41885EBA2ACEQ35649797-37738D6E-7C57-4438-A90F-72452AF54166Q35661905-00B8D451-5BEB-44AB-B62C-E3BB29D266F5Q35854630-9FA10ABB-9290-49A6-9171-9F94BEA521D0Q35895001-3952117E-E060-4CFF-9783-4C408A8206E9Q35968508-0B3B640B-2F86-4D1F-8C96-AB733C811AEFQ36026644-F393DAC8-F546-49D0-8830-DE9DD64AE287Q36032171-7804B259-740F-4593-BAEB-2D108D672BEAQ36978926-A1F983A1-D96B-41E8-B706-A058CBB9FAFAQ36978940-EB961F5B-101C-484E-B719-0DD746FCB2A2Q37157209-5F15422D-726C-4C6B-A13D-394488670028Q37252772-96433C7E-7822-4322-B224-A9A2DC79882BQ37252913-C7BDF9B7-FB8B-4EAC-9F7B-EBA4E212379AQ37409258-96044FB7-CF6E-45E5-AFC6-4031EA3D763BQ37466832-1264F9DA-1161-4040-9A42-14534AD7410AQ37469163-4A9B5EEE-7FAD-4D97-BFC6-58B59BEF8800Q37571973-1EC96C46-C536-4895-8C59-8E64485F3C53Q37966761-1AC361AE-3D4E-4B2A-9733-5D2640BC3B8AQ38121489-D068E163-A29F-4902-8B75-7C6E7B93252EQ38746325-0387F724-BE06-4AE7-BB94-49B1449D9FE9Q38925831-F6B2D7F5-08F3-40A0-B460-AA17D5BAA668Q40043345-247DBBEE-578F-44DD-8787-C939D083FA2BQ40129327-0B787F0D-5561-4176-9726-4E2FD9E8923EQ40457741-AF9F04AB-FC78-469E-B396-618D6DCB3A01Q40478687-B69412F9-BED0-4D8D-A9A7-000BE5A7D2FEQ40606349-D3FA0A8D-4F38-4761-A4D4-D3568F7BB3C5Q40850502-BD64A9EC-8504-47B2-9B5E-19106D5321ABQ43564279-EE5455B8-781B-4E08-B5D5-EF1F891CC856Q44183668-A77E9B16-C3EF-4739-89F0-F402F374A55DQ45325496-F31D3ABC-178F-4303-AC8B-8FB3D5DDBA6EQ47550759-450B3937-F91C-4EE9-93AA-71B85D18DBBCQ47552410-0BA0E0A8-76FC-4D9C-8A21-704A3EE9A943Q57078025-0A93D0B9-19DB-42F2-B50D-CA2A2CD4DFC0
P2860
The cytokine network of acute HIV infection: a promising target for vaccines and therapy to reduce viral set-point?
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
The cytokine network of acute ...... apy to reduce viral set-point?
@ast
The cytokine network of acute ...... apy to reduce viral set-point?
@en
type
label
The cytokine network of acute ...... apy to reduce viral set-point?
@ast
The cytokine network of acute ...... apy to reduce viral set-point?
@en
prefLabel
The cytokine network of acute ...... apy to reduce viral set-point?
@ast
The cytokine network of acute ...... apy to reduce viral set-point?
@en
P2860
P921
P1433
P1476
The cytokine network of acute ...... apy to reduce viral set-point?
@en
P2093
François Villinger
P2860
P304
P356
10.1371/JOURNAL.PPAT.1002055
P5008
P577
2011-08-11T00:00:00Z